首页> 外文期刊>Bone marrow transplantation >Prognostic value of T-1 cell numbers prior to allogeneic stem cell transplantation in patients with severe graft-versus-host disease.
【24h】

Prognostic value of T-1 cell numbers prior to allogeneic stem cell transplantation in patients with severe graft-versus-host disease.

机译:同种异体干细胞移植之前T-1细胞数量对严重移植物抗宿主病患者的预后价值。

获取原文
获取原文并翻译 | 示例
           

摘要

Assessment of risk factors for acute graft-versus-host disease (aGvHD) might help in tailoring the intensity of prophylactic immunosuppression after allogeneic stem cell transplantation (SCT), thereby decreasing the relapse rate in leukaemia patients. In this study, we analysed whether the number of recipient blood T cells and plasma levels of different cytokines were correlated with the risk of aGvHD after allogeneic SCT. Analyses were performed in 23 patients receiving pSCT immediately before or during the first 2 days of the conditioning regimen. In all, 40 or more Tc-1 cells/microl pretransplant were associated with a significantly increased risk of aGvHD (10/10 patients with GvHD>/=II; 4/13 patients without aGvHD with a Tc-1 number >40/microl, P<0.002, Fisher's exact test). In addition, 40 or more Th-1 cells/microl pretransplant were also associated with a significantly increased risk of aGvHD (P<0.04, Fisher's exact test). Furthermore, the number of Th-2 cells was significantly higher in patientswith severe aGvHD even though the median absolute cell counts were very low. However, all other investigated parameters did not reveal predictive value. In conclusion, determination of T-1 cells prior to SCT might determine patients with high/low risk of aGvHD and could thus be used to control immunosuppression after SCT.
机译:评估急性移植物抗宿主病(aGvHD)的危险因素可能有助于调整同种异体干细胞移植(SCT)后预防性免疫抑制的强度,从而降低白血病患者的复发率。在这项研究中,我们分析了异基因SCT后受体血T细胞的数量和血浆中不同细胞因子的水平是否与aGvHD的风险相关。在条件治疗方案的前两天之前或之中,对23例接受pSCT的患者进行了分析。总共,40或更多的Tc-1细胞/微移植前移植与aGvHD的风险显着增加相关(10/10的GvHD> / = II患者; 4/13的无aGvHD的患者Tc-1值> 40 / microl ,P <0.002,Fisher精确检验)。另外,40个或更多的Th-1细胞/微移植前也与aGvHD的风险显着增加有关(P <0.04,Fisher精确检验)。此外,即使中位绝对细胞计数非常低,重度aGvHD患者的Th-2细胞数量也明显更高。但是,所有其他调查的参数都没有揭示预测价值。总之,在SCT之前确定T-1细胞可能会确定aGvHD风险高/低的患者,因此可用于控制SCT后的免疫抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号